Development of a living membrane comprising a functional human renal proximal tubule cell monolayer on polyethersulfone polymeric membrane

Acta Biomaterialia

Volumn 14, Issue , 2015, Pages 22-32

  Schophuizen, Carolien M S ^a,b   De Napoli, Ilaria E ^c   Jansen, Jitske ^a,b   Teixeira, Sandra ^c   Wilmer, Martijn J ^b   Hoenderop, Joost G J ^b   Van Den Heuvel, Lambert P W ^a,d   Masereeuw, Rosalinde ^b   Stamatialis, Dimitrios ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Human kidney proximal tubule cells; L DOPA; Living membrane; Membrane biofunctionalization; Renal assist device

Indexed keywords

BIOLOGICAL ORGANS; CELLS; COATINGS; CYTOLOGY; ION EXCHANGE; MEMBRANES; MONOLAYERS; POSITIVE IONS;

ASSIST DEVICE; BIOFUNCTIONALIZATION; CELL MONOLAYERS; HUMAN KIDNEY; HUMAN KIDNEY PROXIMAL TUBULE CELL; L-DOPA; LIVING MEMBRANE; MEMBRANE BIOFUNCTIONALIZATION; PROXIMAL TUBULES; RENAL ASSIST DEVICE;

FIBER OPTIC SENSORS;

CARBON 14; CIMETIDINE; COLLAGEN TYPE 4; CREATININE; LEVODOPA; METFORMIN; ORGANIC CATION TRANSPORTER 2; POLYETHERSULFONE; PROTEIN ZO1; ARTIFICIAL MEMBRANE; BIOMATERIAL; POLYMER; SULFONE; WATER;

ACTIVE TRANSPORT; ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; BLOOD COMPONENT; CELL ADHESION; CONDITIONALLY IMMORTALIZED PROXIMAL TUBULE EPITHELIAL CELL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISSOLUTION; FILTERS AND MEMBRANES; HUMAN; HUMAN CELL; HYDRAULIC PERMEABILITY; HYDROPHILICITY; IMMORTALIZED CELL LINE; IMMUNOCYTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE CELL; MATERIAL COATING; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MOLECULAR WEIGHT; MONOLAYER CULTURE; NORMAL HUMAN; POLYETHERSULFONE POLYMERIC MEMBRANE; POLYMERIZATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TRANSCYTOSIS; WATER TRANSPORT; CYTOLOGY; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; PERMEABILITY; SCANNING ELECTRON MICROSCOPY; TRANSFORMED CELL LINE;

CELL ADHESION; CELL LINE, TRANSFORMED; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN TYPE IV; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; LEVODOPA; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, SCANNING; PERMEABILITY; POLYMERS; SULFONES; WATER;

EID: 84921831300     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.12.002     Document Type: Article

References (55)

1. USRDS. 2014 Annual Data Report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014.
2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-30.
3. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
4. Meyer TW, Walther JL, Pagtalunan ME, Martinez AW, Torkamani A, Fong PD, et al. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 2005;68:867-77.
5. Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010;25:212-8.
6. El-Sheikh AA, Masereeuw R, Russel FG. Mechanisms of renal anionic drug transport. Eur J Pharmacol 2008;585:245-55.
7. Schophuizen CM, Wilmer MJ, Jansen J, Gustavsson L, Hilgendorf C, Hoenderop JG, et al. Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter. Pflugers Arch 2013;465:1701-14.
8. Humes HD, Buffington D, Westover AJ, Roy S, Fissell WH. The bioartificial kidney: current status and future promise. Pediatr Nephrol 2014;29:343-51.
9. Jansen J, Fedecostante M, Wilmer MJ, van den Heuvel LP, Hoenderop JG, Masereeuw R. Biotechnological challenges of bioartificial kidney engineering. Biotechnol Adv 2014;32:1317-27.
10. Oo ZY, Deng R, Hu M, Ni M, Kandasamy K, bin Ibrahim MS, et al. The performance of primary human renal cells in hollow fiber bioreactors for bioartificial kidneys. Biomaterials 2011;32:8806-15.
11. Fey-Lamprecht F, Gross U, Groth TH, Albrecht W, Paul D, Fromm M, et al. Functionality of MDCK kidney tubular cells on flat polymer membranes for biohybrid kidney. J Mater Sci Mater Med 1998;9:711-5.
12. Fey-Lamprecht F, Groth T, Albrecht W, Paul D, Gross U. Development of membranes for the cultivation of kidney epithelial cells. Biomaterials 2000;21:183-92.
13. Sato Y, Terashima M, Kagiwada N, Tun T, Inagaki M, Kakuta T, et al. Evaluation of proliferation and functional differentiation of LLC-PK1 cells on porous polymer membranes for the development of a bioartificial renal tubule device. Tissue Eng 2005;11:1506-15.
14. Kanai N, Fujita Y, Kakuta T, Saito A. The effects of various extracellular matrices on renal cell attachment to polymer surfaces during the development of bioartificial renal tubules. Artif Organs 1999;23:114-8.
15. Zhang H, Tasnim F, Ying JY, Zink D. The impact of extracellular matrix coatings on the performance of human renal cells applied in bioartificial kidneys. Biomaterials 2009;30:2899-911.
16. + active transport and morphological changes for bioartificial renal tubule cell device using Madin-Darby canine kidney cells. Tissue Eng 2002;8:13-24.
17. Ip TK, Aebischer P, Galletti PM. Cellular control of membrane permeability. Implications for a bioartificial renal tubule. ASAIO Trans 1988;34:351-5.
18. van der Aa MA, Helmerhorst TJ, Siesling S, Riemersma S, Coebergh JW. Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003. Int J Gynecol Cancer 2010;20:638-45.
19. Oliver JA, Barasch J, Yang J, Herzlinger D, Al-Awqati Q. Metanephric mesenchyme contains embryonic renal stem cells. Am J Physiol Renal Physiol 2002;283:F799-809.
20. Lee H, Rho J, Messersmith PB. Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings. Adv Mater 2009;21:431-4.
21. Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007;318:426-30.
22. Humes HD, MacKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 1999;55:2502-14.
23. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 2003;14:454-61.
24. Inagaki M, Yokoyama TA, Sawada K, Duc VM, Kanai G, Lu J, et al. Prevention of LLC-PK(1) cell overgrowth in a bioartificial renal tubule device using a MEK inhibitor, U0126. J Biotechnol 2007;132:57-64.
25. Terashima M, Fujita Y, Sugano K, Asano M, Kagiwada N, Sheng Y, et al. Evaluation of water and electrolyte transport of tubular epithelial cells under osmotic and hydraulic pressure for development of bioartificial tubules. Artif Organs 2001;25:209-12.
26. Shitara Y, Horie T, Sugiyama Y. Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 2006;27:425-46.
27. Tahara H, Kusuhara H, Endou H, Koepsell H, Imaoka T, Fuse E, et al. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther 2005;315:337-45.
28. Fissell WH, Manley S, Westover A, Humes HD, Fleischman AJ, Roy S. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J 2006;52:221-7.
29. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578-88.
30. Wilmer MJ, Saleem MA, Masereeuw R, Ni L, Van Der Velden TJ, Russel FG, et al. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 2010;339:449-57.
31. Jansen J, Schophuizen CM, Wilmer MJ, Lahham SH, Mutsaers HA, Wetzels JF, et al. A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue. Exp Cell Res 2014;323:87-99.
32. Wilmer MJ, Saleem MA, Masereeuw R, Ni L, van der Velden TJ, Russel FG, et al. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 2010;339:449-57.
33. Tijink M, Janssen J, Timmer M, Austen J, Aldenhoff Y, Kooman J, et al. Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate. J Mater Chem B 2013;1:6066-77.
34. Sweet DH, Miller DS, Pritchard JB. Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. Am J Physiol Renal Physiol 2000;279:F826-34.
35. Green D, Perry R. Perry's chemical engineers' handbook. 8th ed. New York: McGraw-Hill Education; 2007.
36. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.
37. Kokko JP, Burg MB, Orloff J. Characteristics of NaCl and water transport in the renal proximal tubule. J Clin Invest 1971;50:69-76.
38. Azari S, Zou L. Using zwitterionic amino acid L-DOPA to modify the surface of thin film composite polyamide reverse osmosis membranes to increase their fouling resistance. J Membr Sci 2012;401-402:68-75.
39. Azari S, Zou L, Cornelissen E, Mukai Y. Facile fouling resistant surface modification of microfiltration cellulose acetate membranes by using amino acid L-DOPA. Water Sci Technol 2013;68:901-8.
40. Cheng C, Li S, Zhao W, Wei Q, Nie S, Sun S, et al. The hydrodynamic permeability and surface property of polyethersulfone ultrafiltration membranes with mussel-inspired polydopamine coatings. J Membr Sci 2012;417-418:228-36.
41. McCloskey BD, Park HB, Ju H, Rowe BW, Miller DJ, Chun BJ, et al. Influence of polydopamine deposition conditions on pure water flux and foulant adhesion resistance of reverse osmosis, ultrafiltration, and microfiltration membranes. Polymer 2010;51:3472-85.
42. Bernsmann F, Ponche A, Ringwald C, Hemmerle J, Raya J, Bechinger B, et al. Characterization of dopamine-melanin growth on silicon oxide. J Phys Chem C 2009;113:8234-42.
43. Ito K, Suzuki H, Horie T, Sugiyama Y. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm Res 2005;22:1559-77.
44. Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstadt H, et al. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 2012;18:1101-8.
45. Perrone RD. Means of clinical evaluation of renal disease progression. Kidney Int Suppl 1992;36:S26-32.
46. Raghavan V, Rbaibi Y, Pastor-Soler NM, Carattino MD, Weisz OA. Shear stress-dependent regulation of apical endocytosis in renal proximal tubule cells mediated by primary cilia. Proc Natl Acad Sci U S A 2014;111:8506-11.
47. Brown CD, Sayer R, Windass AS, Haslam IS, De Broe ME, D'Haese PC, et al. Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 2008;233:428-38.
48. Grundemann D, Koster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, et al. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 1998;273:30915-20.
49. Pinto-do OP, Soares-da-Silva P. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br J Pharmacol 1996;118:741-7.
50. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012;23:1258-70.
51. Mutsaers HA, Wilmer MJ, van den Heuvel LP, Hoenderop JG, Masereeuw R. Basolateral transport of the uraemic toxin p-cresyl sulfate: role for organic anion transporters? Nephrol Dial Transplant 2011;26:4149.
52. Mutsaers HA, Engelke UF, Wilmer MJ, Wetzels JF, Wevers RA, van den Heuvel LP, et al. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients. PLoS ONE 2013; 8:e71199.
53. Weinbaum S, Duan Y, Satlin LM, Wang T, Weinstein AM. Mechanotransduction in the renal tubule. Am J Physiol Renal Physiol 2010;299:F1220-36.
54. McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol 2010;298:R851-61.
55. Wang T. Flow-activated transport events along the nephron. Curr Opin Nephrol Hypertens 2006;15:530-6.